CN Stock MarketDetailed Quotes

InnoCare Pharma (688428)

Watchlist
  • 30.80
  • -0.50-1.60%
Market Closed Apr 17 15:00 CST
54.35BMarket Cap84.62P/E (TTM)

InnoCare Pharma (688428) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
抗肿瘤类药物1.44B60.73%
技术授权收入904.04M38.07%
Research and development services26.34M1.11%
Testing service2.16M0.09%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry2.37B99.91%
Other business2.16M0.09%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory1.44B60.60%
Overseas935.79M39.40%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More